logo
Nissan stuns vehicle buyers with new ultra-affordable electric vehicle — and it's far from bare-bones

Nissan stuns vehicle buyers with new ultra-affordable electric vehicle — and it's far from bare-bones

Yahooa day ago

Nissan is stepping up its electric vehicle game by cutting back the price of its newest EV. According to Electrek, the new Nissan N7 sedan, which was recently unveiled at the Shanghai International Automobile Industry Exhibition, starts at only $16,500.
This may be Nissan's attempt at competing with Chinese EV giant BYD, which recently released the Qin L for $16,500.
Despite the low price, the N7 isn't some bare-bones EV without any flashy smart tech. It comes with high-speed navigation, city memory navigation, as well as intelligent parking, all of which can be controlled using the 15.6-inch infotainment monitor. It also comes with AI voice interaction.
The N7 doesn't sacrifice much on range either. It comes in five different models, which can trek from 316 miles on a single charge to 388.
One of the reasons Nissan is able to sell the N7 for so cheap is because it has a lithium iron phosphate battery pack rather than a lithium-ion battery made using nickel, manganese, and cobalt like a lot of EVs. LFP batteries are significantly cheaper to manufacture. Volkswagen used the same strategy in manufacturing its new affordable EV, the ID.2.
Unfortunately, none of the affordable EVs mentioned here will be hitting the streets in the United States any time soon, though that could always change with enough consumer demand. For now, the N7 and Qin L are focused on the Chinese market, and the ID.2 is targeting the European market.
EVs already have well-known money-saving benefits over gas-powered vehicles in that they don't require as much maintenance and the driver doesn't need to worry about fluctuating gas prices. That's on top of the fact that EVs don't produce planet-warming pollution that contributes to extreme weather events.
But for some, EVs might not have been an option because they're generally a little more expensive. Cheaper EVs such as the N7 could convince consumers to make their next car an EV.
Home solar can increase the savings from owning an EV by cutting charging costs. Charging at home using solar power is cheaper than using public charging stations or energy from the grid. EnergySage provides homeowners with a free service that helps them compare quotes from vetted solar installers as well as any rebates or tax incentives for going solar. Additionally, Palmetto has a solar leasing program called LightReach, which helps you install panels on your home for no money down and still lock in low energy rates.
If you were going to purchase an EV, which of these factors would be most important to you?
Cost
Battery range
Power and speed
The way it looks
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FAW Toyota launches new bZ5 electric SUV
FAW Toyota launches new bZ5 electric SUV

Yahoo

time10 minutes ago

  • Yahoo

FAW Toyota launches new bZ5 electric SUV

FAW Toyota Motor Company, one of Toyota's main Chinese joint ventures, officially launched its new competitively-priced bZ5 battery-powered SUV on the local market, as the Japanese automaker looks to strengthen its foothold in China's fast-expanding new energy vehicle (NEV) market. The new bZ5 is available initially in four main variants, the 550 Joy, 550 Pro, 550 Pro Smart Drive and the 630 Pro, offering varying levels of equipment and trim, and with prices ranging between CNY 129,800 and CNY 159,800 yuan (US$ 18,100-US$ 22,300), inclusive of manufacturer incentives. The bZ5 550 models are powered by 200 kW motors, with their standard battery pack offering a maximum range of 550 km on a single charge. The come with features such as 16-inch central touchscreen, 5G connectivity, and AI-powered voice control. The 630 Pro model has an extended range of 630 km. The bZ5 range is designed to compete with the Tesla Model Y, China's best-selling battery-powered SUV, and is priced significantly lower than the Model Y's starting price of CNY263,500 while offering a similar range. "FAW Toyota launches new bZ5 electric SUV" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

BYD Introduces Most Affordable EV Model in the United Kingdom
BYD Introduces Most Affordable EV Model in the United Kingdom

Yahoo

time10 minutes ago

  • Yahoo

BYD Introduces Most Affordable EV Model in the United Kingdom

BYD Company Limited BYDDY, an EV manufacturer in China, has introduced its most affordable model in the United Kingdom as part of its broader strategy to surpass Tesla as the world's leading electric vehicle manufacturer. The newly launched Dolphin Surf is the European version of BYD's top-selling Chinese model, the Seagull, which recently saw its price drop to just $7,800 in China following further the China Automobile Manufacturers Association didn't name BYD directly, it recently cautioned that ongoing price reductions are fueling fears of a renewed price war in the Chinese EV market. BYD's Dolphin Surf, priced from around $25,000, appears to be extending that pricing pressure into the United Kingdom, BYD outpaced Tesla in monthly vehicle registrations last month, selling 3,025 vehicles compared to Tesla's 2,016 units, and is on track to challenge Tesla's full-year performance. In April, BYD also overtook Tesla in European registrations for the first time, even before the Dolphin Surf entered the the UK's least expensive EV is the Dacia Spring, starting at $20,000 with a WLTP range of 140 miles. BYD's base Dolphin Surf 'Active' variant offers a 203-mile range, while the 'Boost' version extends that to 305 miles and starts at $30,000. Both models come equipped with premium features, such as a 10.1-inch rotatable touchscreen and smart driving functions. Although EVs already tend to be cheaper to own than petrol cars, the emergence of compact, low-cost EVs is seen as key to attracting more budget-conscious buyers. BYD's rapid growth in Europe continues despite the European Union imposing 17.4% tariffs on its vehicles due to concerns over Chinese government subsidies. The United Kingdom, however, has not imposed such tariffs, making it an attractive and increasingly important market for BYD. BYD has a Zacks Rank #5 (Strong Sell) at better-ranked stocks in the auto space are CarGurus, Inc. CARG, Strattec Security Corporation STRT and Michelin MGDDY, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks Zacks Consensus Estimate for CARG's 2025 sales and earnings implies year-over-year growth of 4.96% and 25%, respectively. EPS estimates for 2025 and 2026 have improved 30 cents and 44 cents, respectively, in the past 60 Zacks Consensus Estimate for STRT's fiscal 2025 sales and earnings implies year-over-year growth of 3.49% and 8.11%, respectively. EPS estimates for fiscal 2025 and 2026 have improved 73 cents and 91 cents, respectively, in the past 60 Zacks Consensus Estimate for MGDDY's 2025 sales and earnings implies year-over-year growth of 1.69% and 37.76%, respectively. EPS estimates for 2025 have improved a penny in the past 30 days. EPS estimates for 2025 have improved 3 cents in the past seven days. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Strattec Security Corporation (STRT) : Free Stock Analysis Report Michelin (MGDDY) : Free Stock Analysis Report CarGurus, Inc. (CARG) : Free Stock Analysis Report Byd Co., Ltd. (BYDDY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China

Yahoo

timean hour ago

  • Yahoo

Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China

SINGAPORE, June 14, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics. The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish a next-generation sequencing (NGS) laboratory. The lab will focus on accelerating access to early cancer detection and molecular residual disease (MRD) monitoring using AI-powered circulating tumor DNA (ctDNA) technologies, tailored to address the unique clinical needs of southern China's healthcare landscape. USKBio brings extensive expertise in Polymerase Chain Reaction (PCR)-based In Vitro Diagnostics (IVD) and Good Manufacturing Practice (GMP)-certified production capabilities. Gene Solutions contributes its leadership in NGS-based oncology applications, highlighted by its groundbreaking SPOT-MAS test — Asia's first clinically validated multi-cancer early detection (MCED) assay, validated through a prospective study of 9,024 participants. Additionally, Gene Solutions recently published a real-world MRD study involving 623 patients across six cancer types—lung, colorectal, breast, gastric, liver, and ovarian—demonstrating the clinical utility of ctDNA for monitoring treatment response and assessing recurrence risk. This partnership will focus on localizing and validating these cutting-edge technologies for the Chinese market while fostering joint R&D and production of advanced IVD medical devices. This alliance represents a major step forward in delivering accessible, high-impact, personalized cancer diagnostics to a broader population in China. "This partnership with USKBio allows us to move quickly in establishing a high-impact oncology hub in southern China," said Dr. Nguyen Hoai Nghia, CEO and Co-founder at Gene Solutions. "Together, we aim to bring early, accurate, and scalable cancer screening and diagnostics to more patients, ultimately improving cancer outcomes." "Gene Solutions and USKBio are highly complementary in their core technologies, regional markets, and business models." said Dr. Yu Dehua, CEO at USKbio. "This strategic collaboration will leverage both parties' strengths, creating strong synergies to deliver greater benefits to cancer patients across the Asia region." The partnership also includes technology transfer, technical training, and joint commercialization efforts to ensure rapid deployment and widespread adoption of these advanced genomic tools. About Shenzhen USKBio Founded in August 2015, Shenzhen USKBio is a national high-tech biological enterprise established by leading Chinese and American scientists and entrepreneurs. Specializing in in vitro molecular diagnostics, USKBio integrates R&D, production, marketing, and medical testing services, with a robust presence in IVD reagents, diagnostic instruments, and testing services. Leveraging proprietary technologies such as Udx-PCR and Udx-MSP, the company offers innovative solutions for early cancer screening, precision diagnosis, and companion diagnostics. With over 36 authorized patents and collaborations across top hospitals and testing institutions in China, USKBio is a rising leader in the global molecular diagnostics industry, dedicated to advancing precision medicine. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at: View original content to download multimedia: SOURCE Gene Solutions Genomics Pte Ltd Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store